CEMI Past Earnings image   This CEMI past earnings page last updated 11/7/2022
CEMI Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/3/2022-0.210
Q2 20228/4/2022-0.230
Q1 20225/5/2022-0.290
Q4 20213/3/2022-0.320
Q3 202111/4/2021-0.24
Q2 20218/5/2021-0.450
Q1 20215/6/2021-0.220
Q4 20203/11/2021-0.350
Q3 202011/5/2020-0.270
Q2 20208/6/2020-0.420
Q1 20205/4/2020-0.250
Q4 20193/12/2020-0.230
Q3 201911/7/2019-0.220
Q2 20198/6/2019-0.190
Q1 20195/1/2019-0.140
Q4 20183/7/2019-0.21
Q3 201811/8/2018-0.16
Q2 20188/8/2018-0.12
Q1 20185/9/2018-0.05
Q4 20173/8/2018-0.16
Q3 201711/8/2017-0.05
Q2 20178/9/2017-0.18
Q1 20175/9/2017-0.13
Q4 20163/7/2017-0.21
Q3 201611/10/2016-0.19
Q2 20168/4/2016-0.25
Q1 20165/12/2016-0.03
Q4 20153/8/2016-0.07
Q3 201511/12/2015-0.05
Q2 20158/6/2015-0.07
Q1 20155/7/2015-0.07
Q4 20143/5/2015-0.05
Q3 201411/6/2014-0.03
Q2 20148/7/2014-0.02
Q1 20145/8/2014-0.02
Q4 20133/6/2014-0.03
Q3 201311/7/20130.07
Q2 20138/8/2013-0.03
Q1 20135/9/20130.04
Q4 20123/7/20130.06
Q3 201211/13/2012-0.03
CEMI Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/3/20220.01B
Q2 20228/4/20220.01B
Q1 20225/5/20220.02B
Q4 20213/3/20220.02B
Q3 202111/4/20210.01B
Q2 20218/5/20210.01B
Q1 20215/6/20210.01B
Q4 20203/11/20210.01B
Q3 202011/5/20200.01B
Q2 20208/6/20200.01B
Q1 20205/4/20200.01B
Q4 20193/12/20200.01B
Q3 201911/7/20190.01B
Q2 20198/6/20190.01B
Q1 20195/1/20190.01B
Q4 20183/7/20197.59M
Q3 201811/8/20189.38M
Q2 20188/8/20188.72M
Q1 20185/9/20187.72M
Q4 20173/8/20185.99M
Q3 201711/8/20177.59M
Q2 20178/9/20174.12M
Q1 20175/9/20176.33M
Q4 20163/7/20174.25M
Q3 201611/10/20163.75M
Q2 20168/4/20163.27M
Q1 20165/12/20166.60M
Q4 20153/8/20164.42M
Q3 201511/12/20156.89M
Q2 20158/6/20156.72M
Q1 20155/7/20155.62M
Q4 20143/5/20157.09M
Q3 201411/6/20147.31M
Q2 20148/7/20147.42M
Q1 20145/8/20145.81M
Q4 20133/6/20147.86M
Q3 201311/7/20139.04M
Q2 20138/8/20135.39M
Q1 20135/9/20136.68M
Q4 20123/7/20137.87M
Q3 201211/13/20125.01M
Quotes delayed 20 minutes

Email EnvelopeFree CEMI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Chembio Diagnostics (CEMI) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CERC Past Earnings
CERE Past Earnings
CERS Past Earnings
CFMS Past Earnings
CFRX Past Earnings
CGEM Past Earnings
CHE Past Earnings
CHMA Past Earnings
CHRS Past Earnings
CI Past Earnings

CEMI Past Earnings Q&A

What was the best and worst CEMI past earnings results?
For Chembio Diagnostics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest CEMI past earnings result in our data set was 0.07/share posted in Q3 2013, while the lowest was in Q2 2021 when CEMI posted -0.450/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when CEMI reported 0.02B in revenue, while the quarter with the lowest revenue in our data set was Q2 2016 at 3.27M of revenue.

  Suggested answer: There are 41 CEMI past earnings results in our data set.

On this page we presented the CEMI past earnings date information for Chembio Diagnostics. Reviewing that CEMI Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2013, when CEMI posted gaap of 0.07/share. Meanwhile the lowest CEMI past earnings result was in Q2 2021, when CEMI posted gaap of -0.450/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when CEMI reported 0.02B in revenue, while the smallest revenue quarter was Q2 2016 when CEMI reported 3.27M in revenue.

Any self directed investor doing their due diligence on CEMI or any other given stock can benefit from researching all of the Chembio Diagnostics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Chembio Diagnostics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CEMI. Thanks for visiting, and the next time you need to research CEMI past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: OCDX shares outstanding history, Coca-Cola Stock Split History, POTX Videos.

 

CEMI Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.